Ad is loading...
ATXS
Price
$9.37
Change
-$0.72 (-7.14%)
Updated
Nov 15 closing price
109 days until earnings call
IOBT
Price
$0.82
Change
-$0.07 (-7.87%)
Updated
Nov 15 closing price
130 days until earnings call
Ad is loading...

ATXS vs IOBT

Header iconATXS vs IOBT Comparison
Open Charts ATXS vs IOBTBanner chart's image
Astria Therapeutics
Price$9.37
Change-$0.72 (-7.14%)
Volume$284.44K
CapitalizationN/A
IO Biotech
Price$0.82
Change-$0.07 (-7.87%)
Volume$377.6K
CapitalizationN/A
ATXS vs IOBT Comparison Chart
Loading...
ATXS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
IOBT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
ATXS vs. IOBT commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATXS is a Sell and IOBT is a Sell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (ATXS: $9.37 vs. IOBT: $0.82)
Brand notoriety: ATXS and IOBT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATXS: 89% vs. IOBT: 75%
Market capitalization -- ATXS: $528.79M vs. IOBT: $54.02M
ATXS [@Biotechnology] is valued at $528.79M. IOBT’s [@Biotechnology] market capitalization is $54.02M. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATXS’s FA Score shows that 0 FA rating(s) are green whileIOBT’s FA Score has 1 green FA rating(s).

  • ATXS’s FA Score: 0 green, 5 red.
  • IOBT’s FA Score: 1 green, 4 red.
According to our system of comparison, IOBT is a better buy in the long-term than ATXS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATXS’s TA Score shows that 5 TA indicator(s) are bullish while IOBT’s TA Score has 5 bullish TA indicator(s).

  • ATXS’s TA Score: 5 bullish, 5 bearish.
  • IOBT’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both ATXS and IOBT are a good buy in the short-term.

Price Growth

ATXS (@Biotechnology) experienced а -20.73% price change this week, while IOBT (@Biotechnology) price change was -25.45% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

ATXS is expected to report earnings on Mar 06, 2025.

IOBT is expected to report earnings on Mar 27, 2025.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATXS($529M) has a higher market cap than IOBT($54M). ATXS YTD gains are higher at: 22.005 vs. IOBT (-56.383). IOBT has higher annual earnings (EBITDA): -86.37M vs. ATXS (-92.19M). ATXS has more cash in the bank: 355M vs. IOBT (101M). IOBT has less debt than ATXS: IOBT (2.15M) vs ATXS (5.79M). ATXS (0) and IOBT (0) have equivalent revenues.
ATXSIOBTATXS / IOBT
Capitalization529M54M980%
EBITDA-92.19M-86.37M107%
Gain YTD22.005-56.383-39%
P/E RatioN/AN/A-
Revenue00-
Total Cash355M101M351%
Total Debt5.79M2.15M269%
FUNDAMENTALS RATINGS
ATXS: Fundamental Ratings
ATXS
OUTLOOK RATING
1..100
84
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
54
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATXSIOBT
RSI
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
89%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
88%
Advances
ODDS (%)
Bullish Trend 7 days ago
84%
Bullish Trend 11 days ago
90%
Declines
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
71%
View a ticker or compare two or three
Ad is loading...
ATXS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
IOBT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FTCVX36.20-0.10
-0.28%
Fidelity Advisor Convertible Secs M
FSEKX13.25-0.15
-1.12%
Fidelity Advisor Sustainable U.S. Eq A
AGYGX12.93-0.21
-1.60%
American Century Focused Global Gr Y
FCCGX25.75-0.45
-1.72%
Fidelity Advisor Small Cap Growth C
GSTIX13.76-0.31
-2.20%
Goldman Sachs Strategic Growth Instl

ATXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATXS has been loosely correlated with IMNM. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ATXS jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATXS
1D Price
Change %
ATXS100%
-7.14%
IMNM - ATXS
42%
Loosely correlated
-11.09%
INZY - ATXS
42%
Loosely correlated
-8.89%
KALV - ATXS
41%
Loosely correlated
-3.16%
SNDX - ATXS
39%
Loosely correlated
-5.72%
KYMR - ATXS
39%
Loosely correlated
-8.67%
More

IOBT and

Correlation & Price change

A.I.dvisor indicates that over the last year, IOBT has been loosely correlated with RCKT. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if IOBT jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IOBT
1D Price
Change %
IOBT100%
-7.87%
RCKT - IOBT
37%
Loosely correlated
-5.67%
GLMD - IOBT
36%
Loosely correlated
-5.48%
DYN - IOBT
31%
Poorly correlated
-6.33%
QSI - IOBT
28%
Poorly correlated
-5.77%
ATXS - IOBT
28%
Poorly correlated
-7.14%
More